24 ingredients

CERAMIDE 1

Ceramidesreviewed

Ceramide 1 (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where n has a value ranging from 10 to 20. The INCI Name, Ceramide 1, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 1 will be retained in the retired monograph, and also published with the new name assignment, Ceramide EOP.

View ingredient

CERAMIDE 1 A

Ceramides

Ceramide 1 A (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where n has a value ranging from 10 to 20. The INCI Name, Ceramide 1 A, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 1 A will be retained in the retired monograph, and also published with the new name assignment, Ceramide EOP.

View ingredient

CERAMIDE 2

Ceramides

Ceramide 2 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 14 to 28 and n has a value ranging from 10 to 16. The INCI Name, Ceramide 2, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 2 will be retained in the retired monograph, and also published with the new name assignment as either Ceramide NS or Ceramide NG.

View ingredient

CERAMIDE 3

Ceramidesreviewed

Ceramide 3 (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where m has a value ranging from 12 to 28 in which the acyl moiety may be saturated, mono-unsaturated, or di-unsaturated and n has a value ranging from 10 to 20. The INCI Name, Ceramide 3, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 3 will be retained in the retired monograph, and also published with the new name assignment, Ceramide NP.

View ingredient

CERAMIDE 4

Ceramidesreviewed

Ceramide 4 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsataurated and n has a value ranging from 10 to 16. Ceramide 4 is similar to Ceramide 5, however, the acylating hydroxy acids are generally shorter in Ceramide 4 than in Ceramide 5. The INCI Name, Ceramide 4, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 4 will be retained in the retired monograph, and also published with the new name assignment, Ceramide AS.

View ingredient

CERAMIDE 5

Ceramides

Ceramide 5 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsatuarated and n has a value ranging from 10 to 16. Ceramide 5 is similar to Ceramide 4, however, the acylating hydroxy acids are generally longer in Ceramide 5 than in Ceramide 4. The INCI Name, Ceramide 5, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 5 will be retained in the retired monograph, and also published with the new name assignment, Ceramide AS.

View ingredient

CERAMIDE 6 II

Ceramidesreviewed

Ceramide 6 II (Retired) is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 and n has a value ranging from 12 to 20. The INCI Name, Ceramide 6 II, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 6 II will be retained in the retired monograph, and also published with the new name assignment, Ceramide AP.

View ingredient

CERAMIDE AG

Ceramidesreviewed

Ceramide AG is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.

View ingredient

CERAMIDE AP

Ceramidesreviewed

Ceramide AP, formerly known under the INCI name Ceramide 6 II, is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.

View ingredient

CERAMIDE AS

Ceramidesreviewed

Ceramide AS, formerly known under either of the INCI Names, Ceramide 4 or Ceramide 5, is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.

View ingredient

CERAMIDE ENP

Ceramides

Ceramide ENP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to normal saturated or unsaturated fatty acid which is esterified with saturated long (C14-C26) fatty acids in the 1-O-position.

View ingredient

CERAMIDE EOG

Ceramides

Ceramide EOG is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to an omega-hydroxy acid which is esterified with a saturated or unsaturated fatty acid.

View ingredient

CERAMIDE EOP

Ceramidesreviewed

Ceramide EOP, formerly known under either of the INCI Names, Ceramide 1 or Ceramide 1 A, is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to an omega-hydroxy acid which is esterified with a saturated or unsaturated fatty acid.

View ingredient

CERAMIDE EOS

Ceramidesreviewed

Ceramide EOS is a synthetic N-acylated sphingolipid consisting of Sphingosine having the D-erythro structure linked to an esterified omega-hydroxy saturated or unsaturated fatty acid

View ingredient

CERAMIDE NG

Ceramidesreviewed

Ceramide NG, formerly known under the INCI Name Ceramide 2, is the N-acylated sphingolipid consisting of Sphinganine having the D-erythro structure linked to a normal saturated or unsaturated fatty acid. As opposed to the broader definition for Ceramide 2 which includes sphingolipids consisting of either sphingosine or dihydrosphingosine (sphinganine), Ceramide NG is limited to sphinganine-based ceramides

View ingredient

CERAMIDE NG DILAURATE

Ceramides

Ceramide NG Dilaurate is the diester formed between Ceramide NG and Lauric Acid.

View ingredient

CERAMIDE NP

Ceramidesreviewed

Ceramide NP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to normal saturated or unsaturated fatty acid.

View ingredient

CERAMIDE NP OXOETHOXYDISULFIDE ACETYL ALANYL D-TETRAPEPTIDE-1 AMIDE

Ceramides

Ceramide NP Oxoethoxydisulfide Acetyl Alanyl D-Tetrapeptide-1 Amide is prepared by reacting Ceramide NP and oxoethoxydisulfide with the product obtained by the acetylation of the synthetic peptide consisting of Alanine and D-Tetrapeptide-1 in which the C-terminus is an amide.

View ingredient

CERAMIDE NP OXOETHOXYDISULFIDE ACETYL ALANYL D-TETRAPEPTIDE-1 AMIDES

Ceramides

Ceramide NP Oxoethoxydisulfide Acetyl Alanyl D-Tetrapeptide-1 Amides is a mixture of mono-, di-, and tri-substituted compounds prepared by reacting Ceramide NP and oxoethoxydisulfide with the product obtained by the acetylation of the synthetic peptide consisting of Alanine and D-Tetrapeptide-1 in which the C-terminus is an amide.

View ingredient

CERAMIDE NP STEARATE

Ceramides

Ceramide NP Stearate is the product obtained by the reaction of Ceramide NP and Stearic Acid.

View ingredient

CERAMIDE NS

Ceramidesreviewed

Ceramide NS, formerly known under the INCI Name Ceramide 2, is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to a normal saturated or unsaturated fatty acid. As opposed to the broader definition for Ceramide 2 which includes sphingolipids consisting of either sphingosine or dihydrosphingosine (sphinganine), Ceramide NS is limited to sphingosine-based ceramides.

View ingredient

CERAMIDE NS DILAURATE

Ceramides

Ceramide NS Dilaurate is the diester of Ceramide NS and lauric acid

View ingredient

CERAMIDE NS/PEG-8/SUCCINIC ACID COPOLYMER

Ceramides

Ceramide NS/PEG-8/Succinic Acid Copolymer is a copolymer of Ceramide NS, PEG-8 and Succinic Acid monomers

View ingredient

CERAMIDE OP

Ceramides

Ceramide OP is the organic compound that conforms to the formula, where n=5-15.

View ingredient

Have the full ingredient list?

Paste it into the ingredient checker to see the function of every ingredient.

Check ingredients